DECALIA frischt Management mit neuem Partner auf

Der in Genf ansässige Vermögensverwalter DECALIA hat einen langjährigen Kadermann ins Partnergremium berufen. Die Partner des Genfer Asset Managers DECALIA haben Anfang Juli 2022 Nicolò Miscioscia zum Partner in ihrem Management Committee ernannt, wie der Firmenwebseite zu entnehmen ist. Nachdem Nicolò Miscioscia mehrere Jahre lang die Abteilung Private Markets geleitet hat, wird er den Platz von Isabella Pedrazzini in der Geschäftsleitung […]

DECALIA Capital, subsidiary of DECALIA SA, has structured a minority investment in EDGE Strategy

DECALIA Capital is pleased to announce that on the 1st of July 2022 it successfully structured a minority stake investment into Edge Strategy, a leading global SaaS-based solution to measure, improve and certify gender and intersectional equity, in order to accelerate the international development and support the Founder, Aniela Unguresan, and her management team. EDGE […]

Nicolò Miscioscia appointed new partner of DECALIA SA

The Partners of DECALIA have appointed Mr. Nicolò Miscioscia to join the Management Committee as a partner as of July 2022. After having headed the Private Markets department for several years, Nicolò Miscioscia will take the place of Mrs. Isabella Pedrazzini in the Management Committee. Mrs. Pedrazzini has joined the Board of Directors of DECALIA. […]

Acquisition of a Logistics Asset in Meyrin/Satigny (GE) for Varia Swiss Realtech Properties

Varia Swiss Realtech Properties continues to successfully expand its commercial portfolio with the acquisition of a new logistic/industrial asset strategically located in the dynamic area of Meyrin/Satigny (Geneva). This acquisition is part of a short-term re-leasing strategy, to be followed by a redevelopment of the 11’000 sqm plot. Largely oriented towards light industrial and logistics […]


Eating too much meat is bad for the health, the environment and the conscience The market for plant-based substitutes is transitioning from niche to mainstream Sensory experience, price and availability: the three hurdles to mass adoption